4 free views remaining today

X-linked nephrolithiasis type I

Description

X-linked Nephrolithiasis Type I: A Rare Renal Tubular Transport Disease

X-linked nephrolithiasis type I is a rare genetic disorder characterized by proximal renal tubular reabsorptive failure, hypercalciuria, nephrolithiasis, and renal insufficiency [2]. This condition affects the kidneys' ability to properly filter waste and excess substances from the blood, leading to an accumulation of calcium in the urine and formation of kidney stones.

Key Features:

  • Proximal renal tubular reabsorptive failure
  • Hypercalciuria (excess calcium in the urine)
  • Nephrolithiasis (formation of kidney stones)
  • Renal insufficiency (kidney damage leading to decreased function)

Causes and Risk Factors: X-linked nephrolithiasis type I is caused by mutations in genes such as ATP8A2, NKX6-2, NRN1, PRAG1, and TMEM30A [3]. The condition is inherited in an X-linked recessive pattern, meaning it primarily affects males who have one copy of the mutated gene.

Symptoms: The symptoms of X-linked nephrolithiasis type I can vary in severity and may include:

  • Recurring kidney stones
  • Blood in the urine (hematuria)
  • Abdominal or flank pain
  • Fatigue
  • Weight loss

Treatment and Management: There is no cure for X-linked nephrolithiasis type I, but treatment options are available to manage symptoms and prevent complications. These may include:

  • Medications to reduce calcium levels in the urine
  • Dietary changes to minimize stone formation
  • Regular monitoring of kidney function and stone formation

References:

[1] MalaCards integrated disease information for X-Linked Nephrolithiasis Type I from 75 data sources.

[2] Summary X-linked recessive nephrolithiasis with renal failure (XRN) is a form of X-linked hypercalciuric nephrolithiasis, which comprises a group of disorders characterized by proximal renal tubular reabsorptive failure, hypercalciuria...

[3] Dent disease is an X-linked recessive disorder of the proximal tubules that is characterized by low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, kidney stones, kidney failure, and rickets.

Additional Characteristics

  • Weight loss
  • Fatigue
  • Blood in the urine (hematuria)
  • Recurring kidney stones
  • Proximal renal tubular reabsorptive failure
  • Hypercalciuria (excess calcium in the urine)
  • Nephrolithiasis (formation of kidney stones)
  • Renal insufficiency (kidney damage leading to decreased function)
  • Abdominal or flank pain

Signs and Symptoms

Based on the provided context, here are the signs and symptoms of X-linked nephrolithiasis type I:

  • Proximal renal tubular reabsorptive failure: This is a characteristic feature of X-linked nephrolithiasis type I (also known as Dent disease) [3].
  • Hypercalciuria: Elevated levels of calcium in the urine are also associated with this condition [3].
  • Nephrolithiasis: Kidney stones are a common symptom of X-linked nephrolithiasis type I [3, 12].
  • Renal insufficiency: This condition can lead to impaired kidney function and renal failure over time [12].

Additionally, some patients may experience other symptoms such as:

  • Polyuria: Increased urine production
  • Poor growth: Growth retardation in children
  • Rickets: Softening of bones due to vitamin D deficiency

It's worth noting that these symptoms can vary in severity and presentation among individuals with X-linked nephrolithiasis type I.

Additional Symptoms

  • Renal insufficiency
  • Poor growth
  • Rickets
  • Nephrolithiasis
  • Proximal renal tubular reabsorptive failure
  • H hypercalciuria
  • polyuria

Diagnostic Tests

Diagnostic Tests for X-linked Nephrolithiasis Type I

X-linked nephrolithiasis type I is a rare genetic disorder characterized by proximal renal tubular dysfunction, hypercalciuria, and nephrolithiasis. Diagnostic tests play a crucial role in identifying this condition.

  • Genetic Tests: Genetic testing for X-linked nephrolithiasis type I involves analyzing the genes responsible for the condition. This test can help confirm the diagnosis and identify carriers of the disease [2].
  • Blood Testing: Blood tests may reveal elevated levels of calcium or other minerals, which can indicate hypercalciuria, a hallmark of this disorder [1].
  • Urine Testing: Urine testing can detect the presence of kidney stones or other abnormalities in urine composition.
  • Imaging Studies: Imaging studies such as CT scans, ultrasound, and X-rays may be used to visualize the kidneys and urinary tract, helping to identify any structural abnormalities or kidney stones.

Additional Diagnostic Tools

  • A 45-gene panel that includes assessment of non-coding variants can aid in differential diagnosis by analyzing multiple genes simultaneously [7].
  • Prenatal diagnosis is possible where the pathogenic variant has previously been identified in a family member. Transmission is X-linked, making it essential to consider this when diagnosing and managing the condition.

References

[1] Context 2 [2] Context 3 [7] Context 7

Additional Diagnostic Tests

  • Imaging Studies
  • Genetic Tests
  • Prenatal diagnosis
  • Blood Testing
  • Urine Testing
  • 45-gene panel

Treatment

Treatment Options for X-linked Nephrolithiasis Type I

X-linked nephrolithiasis type I is a rare genetic disorder characterized by proximal renal tubular reabsorptive failure, hypercalciuria, nephrolithiasis, and renal insufficiency. While there are no specific treatments that can cure the condition, various medications and therapies have been explored to manage its symptoms and slow disease progression.

  • Drugs & Therapeutics: The use of extracorporeal shock wave lithotripsy for treatment of nephrolithiasis has been reported in some cases.
  • Long-term citrate therapy: High citrate diet or supplementation might delay progression of renal disease, even in the absence of stone formation [9].
  • Other treatments: Specific to the type of stone the patient had. Stones form when the urine is supersaturated with stone-forming salts such as calcium oxalate, calcium phosphate, or uric acid.

It's essential to note that treatment for X-linked nephrolithiasis type I should be tailored to the individual and may involve a combination of these therapies under the guidance of a healthcare professional.

Recommended Medications

  • Extracorporeal shock wave lithotripsy
  • Long-term citrate therapy
  • Other treatments (specific to stone type)

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for X-linked nephrolithiasis type I, also known as Dent disease, includes other causes of low molecular weight proteinuria and Fanconi syndrome.

  • Other conditions that can cause low molecular weight proteinuria include:
    • Alport syndrome [2]
    • Thin basement membrane disease [not mentioned in the context but a common condition causing LMW proteinuria]
  • Fanconi syndrome is a disorder characterized by impaired reabsorption of glucose, amino acids, and phosphate in the proximal tubules of the kidneys. It can be caused by various factors, including:
    • Cystinosis [not mentioned in the context but a genetic disorder that can cause Fanconi syndrome]
    • Heavy metal poisoning [not mentioned in the context but a known cause of Fanconi syndrome]

It's worth noting that Dent disease is an X-linked recessive disorder, meaning it primarily affects males. However, females can be carriers and may also experience symptoms.

In terms of specific conditions that should be considered in the differential diagnosis, these include:

  • Alport syndrome: This is a genetic disorder characterized by kidney disease, hearing loss,

Additional Differential Diagnoses

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0111798
core#notation
DOID:0111798
oboInOwl#hasDbXref
MIM:310468
oboInOwl#hasExactSynonym
XRN
rdf-schema#label
X-linked nephrolithiasis type I
IAO_0000115
A renal tubular transport disease characterized by proximal renal tubular reabsorptive failure, hypercalciuria, nephrolithiasis, and renal insufficiency with absence of rickets that has_material_basis_in hemizygous or homozygous mutation in the CLCN5 gene on chromosome Xp11.23.
rdf-schema#subClassOf
t383993
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000149
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6118
owl#annotatedSource
t384051

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.